KORU MEDICAL SYSTEMS INC

Insider buying at Koru Medical shows confidence in its subcutaneous infusion growth targets.

Insider buying at KORU Medical Systems shows executive confidence amid market volatility—key insights for investors watching potential FDA and reimbursement milestones.

CEO Tharby Linda M’s recent KORU Medical Systems purchase signals confidence amid volatility, hinting at potential upside as the company pursues growth in subcutaneous infusion devices.

CEO Tharby Linda M’s steady share buys signal confidence in KORU’s future, backed by a strong product pipeline and a rising stock price.

Insider trades reveal KORU Medical Systems’ executives confidently buying shares, hinting at optimism amid a challenging low‑P/E, regulatory‑heavy pipeline. Investors gain a clear, measured insight into the company’s short‑term outlook and long‑term…